http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006523314-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate | 2004-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2006523314-A |
| titleOfInvention | ErbB surface receptor complex as a biomarker |
| abstract | The present invention is directed to a new class of biomarkers in patient samples comprising a dimer of ErbB cell surface membrane receptors. In one aspect, the present invention provides a method for correlating a disease state or health state with the amount of one or more ErbB cell surface membrane receptor dimers measured directly in a patient sample, particularly a fixed tissue sample. A method for determining the status of such a state. In another aspect, the present invention provides a measurement of the amount of one or more ErbB cell surface membrane receptor dimers in a sample cell to determine the presence or absence of a precancerous condition, the presence or absence of a cancerous condition, the prognosis of cancer. Or a method of determining a cancer state in an individual-derived specimen by correlating with the cancer state, including responsiveness to treatment. Preferably, the method of the invention is performed by using a set of binding compounds having releasable molecular tags that are specific for multiple components of one or more types of receptor dimers. . After binding, the molecular tag is released and separated from the assay mixture and analyzed. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009534667-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016517960-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010533842-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019098385-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016520198-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012500008-A |
| priorityDate | 2003-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 163.